Key facts
- This page summarizes Arthur H. Amron's Form 4 filing for NEPHROS INC (NEPH).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 16 Sep 2026, 16:59.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Other
Other
Other
Other
Other
Other
Additional SEC filing notes
Footnote F1
Represents an in-kind distribution from Wexford Partners 11, L.P. ("WP11"), Wexford 11 Advisors LLC ("WP Advisors") and WPIC 2 LLC ("WPIC2", and together with WP11 and WP Advisors, the "Wexford Entities") that does not involve (i) a purchase or a sale of securities or (ii) any additional consideration.
Footnote F2
Represents the common stock of the Issuer held by Amron Holdings LLC ("Amron Holdings").
Footnote F3
Represents a sale of certain shares of common stock from the Wexford Entities to Amron Holdings, the proceeds of which were distributed to certain underlying investors of the Wexford Entities. No Wexford Entities shall receive any compensation, directly or indirectly, in connection with the transaction described herein.
Footnote F4
Arthur Amron may, by reason of his status as a controlling person of Amron Holdings, be deemed to own beneficially the securities held by Amron Holdings. Mr. Amron holds the power to vote and to dispose of the securities held by Amron Holdings.